Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac resynchronization therapy.

Silke Isabelle Trautmann1, Michael Kloss, Angelo Auricchio

  • 1Division of Cardiology, University Hospital Magdeburg, Leipzigerstrae 44, D- 39120, Magdeburg, Germany. angelo.auricchio@medizin.uni-magdeburg.de

Current Cardiology Reports
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain lesions and cognitive decline in patients with atrial fibrillation: a prospective multicentre cohort study.

Swiss medical weekly·2026
Same author

REPLY: The Real Risk-Benefit Ratio of Contemporary Implantable Cardioverter-Defibrillator Therapy Remains Unknown.

JACC. Clinical electrophysiology·2026
Same author

Ischemic brain infarcts, white matter hyperintensities, and cognitive impairment are increased in patients with Atrial Fibrillation.

Communications medicine·2026
Same author

Ablation of atrial fibrillation sources identified through sequential high-density mapping: in silico comparison against anatomy-based approaches.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Swiss national cardiac device registry: Changing trends in implantation procedures over the last two decades.

Cardiology journal·2025
Same author

Contemporary Implantable Cardioverter-Defibrillator Benefit: Time to First Therapy in a Large, Real-World Cohort.

JACC. Clinical electrophysiology·2025
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

Cardiac resynchronization therapy (CRT) improves outcomes for heart failure patients. This review examines randomized trials on CRT, highlighting unanswered questions for future research in heart failure management.

Area of Science:

  • Cardiology
  • Medical Therapy
  • Heart Failure Research

Background:

  • Congestive heart failure (CHF) continues to have high morbidity and mortality despite medical advancements.
  • Conventional atrioventricular (AV) pacing with short AV delay was an early nonpharmacologic treatment for severe CHF.
  • Biventricular pacing, or cardiac resynchronization therapy (CRT), evolved from this approach.

Purpose of the Study:

  • To review randomized trials on cardiac resynchronization therapy (CRT) for heart failure.
  • To identify and discuss unresolved questions in CRT research.
  • To provide an overview of the current evidence for CRT in heart failure management.

Main Methods:

  • Systematic review of published randomized trials.
  • Focus on studies evaluating biventricular pacing (CRT).

Related Experiment Videos

  • Analysis of results to identify areas needing further investigation.

    • Main Results:

    • CRT has emerged as a significant therapeutic option for specific heart failure populations.
    • Evidence from randomized trials supports the efficacy of CRT in improving outcomes.
    • Several key questions regarding patient selection, device optimization, and long-term effects remain.

    Conclusions:

    • Cardiac resynchronization therapy is a crucial nonpharmacologic treatment for selected heart failure patients.
    • Further research is needed to address remaining uncertainties and optimize CRT utilization.
    • Ongoing trials are essential for advancing the understanding and application of CRT.